Search results for "Venous thromboembolism"
COVID-19 guideline update from NIH, postdischarge anticoagulation, remdesivir effects
The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/1.htm
22 Dec 2021
NIH guidelines on anticoagulation in COVID-19; research on statin use, omicron variant
The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
https://acphospitalist.acponline.org/archives/2022/01/12/free/nih-guidelines-on-anticoagulation-research-on-statins-and-COVID-19.htm
12 Jan 2022
VTE readmissions continue more than 30 days after complex cancer surgery
In a retrospective cohort study using U.S. data from 2016, 0.6%, 1.1%, and 1.7% of patients undergoing complex cancer surgery were readmitted with VTE as a primary diagnosis by 30, 90, and 180 days after discharge.
https://acphospitalist.acponline.org/archives/2022/02/02/vte-readmissions-continue-more-than-30-days-after-complex-cancer-surgery.htm
2 Feb 2022
There will be (less) blood
A new patient blood management program reduced transfusions, length of stay, and cost at one hospital.
https://acphospitalist.acponline.org/archives/2022/02/16/there-will-be-less-blood.htm
16 Feb 2022
Diagnosing pulmonary embolism
Experts offer advice on how to apply the wide variety of available validated scores and algorithms, but also clinical judgment, to find pulmonary embolisms without excessive testing.
https://acphospitalist.acponline.org/archives/2022/02/23/free/diagnosing-pulmonary-embolism.htm
23 Feb 2022
Model for COVID-19 triage, updated guidelines for inpatients, negative trial of ivermectin
An electronic health record tool used nine variables to predict which inpatients with COVID-19 would deteriorate. Two societies updated their guidelines on inpatient thromboprophylaxis and remdesivir use. A trial found that ivermectin had no effect on disease progression or mortality.
https://acphospitalist.acponline.org/archives/2022/02/23/free/model-for-covid-19-triage-updated-guidelines-for-inpatients.htm
23 Feb 2022
DOACs better than heparin for periop thromboprophylaxis, review finds
The systematic review and network meta-analysis found lower rates of symptomatic venous thromboembolism in surgical patients given direct oral anticoagulants (DOACs) versus the standard dose of low-molecular-weight heparin, without a significant increase in bleeding.
https://acphospitalist.acponline.org/archives/2022/03/16/doacs-better-than-heparin-for-periop-thromboprophylaxis.htm
16 Mar 2022
Risk for DVT, PE, bleeding after COVID-19, but low long-term VTE recurrence risk
One study found increased risk for deep venous thrombosis (DVT) for up to three months after COVID-19, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while another showed low rates of venous thromboembolism (VTE) recurrence in the year after infection.
https://acphospitalist.acponline.org/archives/2022/04/13/free/risk-for-dvt-pe-bleeding-seen-after-covid-19-long-term-risk-for-vte-recurrence-may-be-low.htm
13 Apr 2022
Continuing aspirin for no reason?
A speaker made the case for anticoagulant monotherapy in selected patients with stable coronary artery disease and atrial fibrillation during a “Things We Do For No Reason” session at SHM Converge 2022.
https://acphospitalist.acponline.org/archives/2022/04/27/continuing-aspirin-for-no-reason.htm
27 Apr 2022
OPAT has similar safety, lower costs versus inpatient antibiotic therapy
Patients receiving outpatient parenteral antimicrobial therapy (OPAT) after hospitalization for bacterial infection had 90-day adverse event rates of 35.6% compared to 39.0% in those who stayed in the hospital for parenteral antimicrobial therapy, a retrospective Canadian study found.
https://acphospitalist.acponline.org/archives/2022/04/27/opat-has-similar-safety-lower-costs-versus-inpatient-antibiotic-therapy.htm
27 Apr 2022